Measurements of bone lead concentrations in the tibia, wrist, sternum, and calcaneus were performed in vivo by x ray fluorescence on active and retired lead workers from two acid battery factories, office personnel in the two factories under study, and control subjects. Altogether 171 persons were included. Lead concentrations in the tibia and ulna (representative of cortical bone) appeared to behave similarly with respect to time but the ulnar measurement was much less precise. In an analogous fashion, lead in the calcaneus and sternum (representative of trabecular bone) behaved in the same way, but sternal measurement was less precise. Groups occupationally exposed to lead were well separated from the office workers and the controls on the basis of calculated skeletal lead burdens, whereas the differences in blood lead concentrations were not as great, suggesting that the use of concentrations of lead in blood might seriously underestimate lead body burden. The exposures encountered in the study were modest, however. The mean blood lead value among active lead workers was 1-45 pmol l1 and the mean tibial lead concentration 21 1 pg (g bone mineral)-'. posure. Calcaneal lead concentration, by contrast, was strongly dependent on the intensity rather than duration of exposure. This indicated that the biological half life of lead in calcaneus was less than the seven to eight year periods into which the duration of exposure was split. Findings for retired workers clearly showed that endogenous exposure to lead arising from skeletal burdens accumulated over a working lifetime can easily produce the dominant contribution to systemic lead concentrations once occupational exposure has ceased.
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Lead is a widely used toxic metal that accumulates in the body. It is concentrated in bone, which contains over 90% of the body burden in adults.'
Occupational exposure to lead is routinely monitored by determination of blood lead concentrations, which largely reflect recent average exposure as the half life of lead in blood is of the order of 35 days.2 Blood lead concentration has been shown to be associated with indicators of adverse effects on haem synthesis, such as free erythrocyte protoporphyrin,'
and with neurophysiological4 and psychological effects. 56 The relation between blood lead concentration and exposure is, however, not necessarily linear7 and, in particular, it has been recognised that in a model of a skeletal subcompartment, the lead should be considered readily exchangeable and constitute an intrinsic source of lead input to the blood.289 In this context, a measurement of the concentration of bone lead may help to distinguish between recent absorption and endogenous release among subjects with high concentrations of blood lead.
Previous studies on in vivo measurement of lead in finger bones'0 and in tibia" have shown a close relation between bone lead concentration and time integrated blood lead concentration used as an estimate of cumulative exposure. Such in vivo measurements are therefore gaining acceptance as a valuable tool that enables relations between exposures to lead and chronic effects on health to be explored in cross sectional studies.69
The aims of our study included the extension of earlier work by measuring the concentration of lead in bone at four different anatomical sites to examine possible variations in the way lead behaves in different types of bone. One bone site was the anterior aspect of the middle of the tibia, because this is largely cortical, is superficial, has a substantial mineral content, and has been measured in many previous studies...... The calcaneus was chosen because it is predominantly trabecular and it is also superficial and substantial; a second mainly trabecular bone, the sternum, was selected because its structural function in the skeleton and its load bearing properties are very different from the calcaneus. The mineral content in the sternum is, however, significantly lower than in the calcaneus. Two alternative trabecular bone sites, vertebra and rib, were considered, but had to be rejected; the vertebra because the x ray fluorescence measurement would be dominated by the cortical spinal processes rather than by trabecular bone, and the rib because its mineral content would be too small to give acceptable precision. Problems would also be caused by movement due to normal breathing. The fourth bone site chosen was the distal end of the wrist, which could be expected to contain a mixture of both cortical and trabecular bone.
The study population was selected to encompass a wide range of exposures. People occupationally exposed to lead, both currently and in the past, were measured, together with referent groups drawn firstly from the factory environment and, secondly, from those exposed only to concentrations found in the general urban environment in southern Finland. Within this population, it was intended to study relations among parameters that could be expected to respond to exposure to lead over a range of time scales. The time weighted average blood lead concentration (indicating average intensity of exposure) was determined, as was the time integrated blood lead concentration (reflecting cumulative exposure). These were to be compared with urinary lead and protoporphyrin concentrations as well as the in vivo determination of bone lead concentration. The overall aim was to explore further the role of monitoring ofbone lead and its interpretation, considering also its possible relation with endogenous release of lead. Lead exposure has been associated with kidney damage'6; therefore, the excretion of retinol binding protein and N-acetylglycosaminidase in the urine was measured to study this association further.
Subjects and methods

SUBJECTS
The subjects were divided into four groups according to their histories of exposure (table 1) . The groups were (1) currently exposed lead factory workers, (2) former lead workers whose occupational exposure had ceased, (3) office workers within the lead factories, and (4) a control group with no known industrial exposure.
The currently exposed group consisted of occupationally exposed lead workers and foremen, whose blood lead concentrations were monitored regularly. The sample comprised 87 workers at two lead acid battery factories, 53 from the first and 34 from the second, whose main exposure was to metallic lead and lead oxide. Also, there were four workers who handled scrap metallic lead and who were mainly exposed to the dust and fumes of lead. The mean age ofthese 91 lead workers was 41 (SD 9) years and their duration of exposure was 12 (SD 8) years. There were 74 men and 17 women in this group, the women having a slightly higher mean age of 46 1 years compared with 39 3 years for the men. This difference reflected the companies' preference for not employing women of child bearing age for jobs with exposure to lead.
The formerly exposed lead workers had all been previously employed at one of the two lead acid battery factories, nine at the first and seven at the second. This group had also been monitored by regular determination of blood lead concentrations and their mean duration and intensity of exposure was similar to that of the current workers. The former worker group consisted of 12 men and four women. Their mean age was 56 (SD 7) years, duration of exposure 15 (SD 8) years, and they had ceased occupational exposure to lead for an average of 3 1 years (median two years). All of these people had stopped working with lead before the normal age of retirement (65 years); the reasons varied, but only in one case was lead implicated in the person's inability to continue normal working.
The factory office workers, 19 men and 19 women, were secretarial, accountancy, sales, and computer staff whose offices were separated from the battery production areas, so that their exposure to lead was minor compared with the shop floor workers. In consequence, their blood lead concentrations had not been monitored regularly. Their mean age was 41 (SD 9) years and their mean duration of employment at the factory 11 (SD 9) years.
The control group consisted of 16 men and 10 women working at the Institute of Occupational Health in Helsinki. They had had no known occupational exposure to lead, so they were exposed to lead only through the general environment in southern Finland. Their mean age was 36 (SD 9) years.
ANALYSIS OF LEAD IN BONE
Concentrations oflead in bone were measured in vivo by x ray fluorescence, exciting the lead K-series x rays using the 88 keV y rays from "'UGd."720 In this To avoid surface contamination, the skin overlying the bone site in question was washed before each measurement.
EXPOSURE INDICATORS FROM BLOOD SAMPLES
Concentrations ofprotoporphyrin IX in whole blood were analysed by haematofluorometry (ZnP hematofluorometer model 4000, Environmental Sciences Associates, Map, USA). The analytical quality of blood lead determinations was controlled with an external quality assurance scheme. Complete blood lead records for all the currently exposed and 13 of the 16 former lead workers were available and were used to compute time weighted average blood lead concentrations (BPbave) and time integrated blood lead concentrations (BPbmt) as shown later. Lead concentrations in blood and urine were determined using flame methods in the 1960s and 1970s, and graphite furnace AAS methods since the 1980s. 
MEASUREMENTS
This study was performed in three phases; in the first phase measurements were made at the first of the two lead acid battery factories (53 current, nine former lead workers, 22 factory based office workers) and 22 of the control group were also seen in this period. In this first phase, the group in Helsinki used a single x ray fluorescence apparatus to measure lead in tibia and in ulna sequentially: in each case the measurement time was 1500 s (live time). The Birmingham group used two sets ofx ray fluorescence apparatus to make simultaneous measurements on calcaneus and sternum, the measurement times being 1800 s (live time). Source activities were all in the range 3 7-7A4 GBq, skin doses at the different sites were in the range 08-1 65 mGy, and the total effective dose equivalent summed over the four measurements did not exceed [15] [16] [17] [18] [19] [20] pSv.
In the second phase ofthe study lead was measured sequentially in tibia, calcaneus, and ulna by the group in Helsinki in the four scrap metal workers. Similarly, in the third part of the study, in vivo concentrations of bone lead measurements were made only by the Helsinki group, in this case in tibia and calcaneus only. This involved workers at the second factory (34 current and seven former lead workers and 16 office workers), together with four of the control group.
Results
EXPOSURE TO LEAD Table 1 shows parameters reflecting exposure to lead in the four different exposure groups. It should be noted that not all data are reported for each parameter. In most cases this was due to incomplete data collection: for example, in phases 2 and 3 of the study measurements of lead concentrations in the sternum were not made, hence the lower number of observations in each exposure category. For BPbi.t it was not possible to construct an adequate history of previous blood lead measurements for these former workers. It was also necessary to exclude a few data because they were clear outliers from the main distribution. For example one lead worker had an apparent lead concentration in sternum of 454 pg (g bone mineral)-', but his tibia and calcaneus concentrations were each about 25 Mg (g bone mineral)-', and his lead concentration in ulna was 116 pg (g bone mineral)-'; given these data, and the fact that his sternum result was around 8a from the mean of the rest ofthe results for active workers, it was concluded that contamination, perhaps in lead in hair, had distorted his result. Two ulnar lead measurements were excluded for similar reasons. The final reason for exclusion of data is illustrated by an office worker who had lead concentrations in tibia, calcaneus, sternum, and ulna of 20, 140, 94, and 90 pg (g bone Protoporphyrin IX concentration, however, which was raised in the active lead workers, was the same in the former workers as in the office workers and the controls. This confirms that these former lead workers were no longer exposed to lead above normal environmental concentrations. It is noteworthy, therefore, that both the blood and urinary lead concentrations, although lower than in the active workers, were significantly raised when compared with the office workers and the controls. This implies strongly that the skeleton acts as a principal endogenous source of lead for these workers no longer currently exposed to lead. The effect is further shown by the correlations between blood lead and BPb=,, tibial lead, and calcaneal lead concentrations (table  3) . Figures 3 and 4 show concentrations of lead in blood and urine as functions of tibial and calcaneal lead respectively. For blood lead a clear trend was seen; it is also apparent that the relation for urinary lead concentrations are heavily influenced by the result of one person, marked with a square in the figure. The regression lines for these relations are as follows with those for urine calculated with the "square" value excluded. BPb = 0-00668 x tibia + 0-372 UPb = 0000534 x tibia + 0-0382 (r=077) (3) (r=074) (4) BPb = 0-00348 x calcaneus + 0-332 (r=O067) (5) UPb=0 000229 x calcaneus+O00391 (r=O053) (6) Concentrations oflead in blood and urine are in imol 1'1 and the bone lead measurements are in pg (g bone mineral)-'. The intercept values for blood and urine (effectively the estimated lead concentration in the absence of any contribution from bone) are comparable with the mean values found in the office workers and somewhat higher than those seen in the control group. Table 1 shows the results of statistical tests for differences in mean values of the parameters for the different exposure groups. Concentrations of lead in blood and urine were different in each group, with blood distinguishing best between groups. Integrated blood lead concentration was higher in the former than in the current lead workers, but the difference was not statistically significant at the 5% level. Of the four bone lead measurements only ulna showed a significant difference between active and former workers, and ulna lead values were similar in all three groups not currently exposed to lead: this was surprising, especially considering that in nine of the 16 former workers the exposure to lead had only ceased for two years or less. Thus there would have As data for ulnar and sternal lead concentrations were limited, the behaviour of lead in tibia and calcaneus was studied more closely, in the manner shown in figs 6 and 7. The active lead workers were divided into nine groups using 33rd and 67th percentiles of the time weighted average blood lead concentrations, reflecting intensity of exposure, and the would increase the uncertainty without improving (7) where the skeletal lead burden is in mg and the tibial and calcaneal lead concentrations are in ,ig (g bone mineral)-'. More detailed information is given by Bigler and Woodard24 and Woodard and White. 25 The first reference lists the different components of the human skeleton as proportions of total bone tissue mass, and the second lists the calcium contents of much the same components of the skeleton and gives the calcium content of cortical bone as 22 20 g per 100 g wet weight and that of spongiosa (or trabecular bone) as 7 47 g per 100 g wet weight in adults. If the total bone mineral mass is again taken to be 2 7 kg, then: Pbskeletal = 1-935 x Pbtibia + 0765 x Pb.l,eus (8) for men and PbskeletIl = 1-951 x Pbtibi. + 0 749 x Pb ,,eus (9) for women; in both cases the units are as in equation (7).
DIFFERENCES AMONG EXPOSURE SUBGROUPS
A fourth possible approach is to consult the data of Wittmers et al26 as they list the lead content of five bone sites. They also compare skeletal lead burden estimated from the five sites with that estimated from tibia alone and with that based on measuring the tibia, predicting the other four site concentrations of lead, and then computing total skeletal burden. They conclude that the maximum deviation between an estimate based on a simple tibia measurement and that based on measurement at five sites is about 13 5% for the age group 21-35 and that this decreases with increasing age, with the possible exception of subjects over 75 years old (not applicable in this study). Their approach would, however, require three separate equations to cover the age ranges encountered in this study which, together with their reassuring conclusion as to the usefulness of more restricted data, meant that this option was not pursued. The use ofthe data of Bigler and Woodard'4 and Woodard and White25 was appealing; however, it necessitated using their tabulated values in a way for which they were not designed. So equation (7) was used for further analysis. Table 4 summarises the skeletal lead burdens thus calculated. The groups occupationally exposed to lead were well separated from both the office workers and the controls, and these two groups differed significantly from each other at the 5% level. The statistical power was thus, not surprisingly, intermediate between that of tibia and that of calcaneus. The magnitude of these skeletal lead values are low compared with those reported by Barry.' His mean body burden of lead in non-occupationally exposed adult men was 165 mg, of which roughly 94% was in bone. This is about double that found in our active lead workers and some 20 times the value for the controls. The mean body burden for occupationally exposed lead workers described by Barry was 566 mg and ranged up to 12 692 mg. On close examination, the difference is seen to be largely reflected in measurements of tibia lead concentration, an important contributor to Barry's burden estimate as it is in our equation (7). Barry's non-occupationally exposed adults, aged 20 years and over (57 of the 60 subjects contributing to the mean body burden value of 165 mg), had a mean tibial lead concentration of 24-3 pg (g wet bone)-', which equates to about 43 pg (g bone mineral)-' (the units we used). This is about double the mean value for tibial lead concentration in the active workers in our study and more than 10 times that of the control group. The mean blood lead values are also different between our different groups, and between our data and those of Barry; however, the differences in concentrations of blood lead were not as great as those for the skeletal burden, suggesting that the use of measurements of blood lead concentrations with an assumption of steady state exposure conditions might seriously underestimate lead body burden. Significance levels; *p < 0-05; **p < 0 01; ***p < 0-001 for differences of means from mean of lead workers group. Similarly t for differences of means from former lead workers' group and I for differences of means from office workers' group. 
LEVELS OF LEAD EXPOSURE
The exposures encountered by workers in this study were modest by comparison with some others reported," for both current and cumulative exposure. The mean blood lead value among active lead workers was 1-45 pmol 1-' compared with 2 48, 1-56, and 2-32 ymol[' at three factories surveyed by Somervaille et al." The mean tibial lead concentration for active workers was 21-1 pg (g bone mineral)-' compared with 54 8, 32 3, and 31-0 pg (g bone mineral)-' at the three English factories. The duration of exposure at the second and third English factories was about 50% longer than here, however, so past amounts of exposure may not have reflected the apparent difference in current practice; this contention is supported by the higher mean tibia concentration of 32-4 pg (g bone mineral)-' seen among the former lead workers in this study.
The degree of lead exposure was clearly higher among office workers than among controls, as is shown by their significantly higher blood and urinary lead concentrations.
Apart from ulna, the bone lead concentrations were all higher among office workers than controls; in the case of calcaneus and sternum significantly so. Therefore the somewhat raised exposure amongst staff employed at the lead factories but not actively engaged on lead related work was a consistent feature of these workplaces. This additional exposure could have arisen from slight contamination of the entire factory site or from occasional visits to the production areas.
The control group exhibited very low values for all the parameters reflecting either current or cumulative lead exposure. Indeed, concentrations were often so low that the results were only interpretable on a group mean basis. That environmental exposure to lead is slight in Finland is reinforced by comparison with the concentrations found in an almost analogous control group drawn from English university staff." There the mean blood lead concentration was 0-63 pmol l-' and the tibial lead concentration was 16-7 pg (g bone mineral)-', three to five times the corresponding concentrations in Finland.
MEASUREMENTS AT DIFFERENT BONE SITES
The data reported by Somervaille et al " raised the possibility that the calcaneus was in some fashion an atypical trabecular bone, and thus was handling lead in a manner not representative of this type of bone in the body as a whole. In this context, the strong correlation between sternal lead and calcaneal lead for the 104 subjects in whom both were measured (r = 0 61) was reassuring as was the apparently similar behaviour of sternal lead to calcaneal lead with regard to intensity and to duration of exposure. The uncertainties on sternum lead measurements were about double those on calcaneal lead measurements, however, and, as can be seen from (fig 7) . This indicates that the biological half life of lead in calcaneus was short compared with the seven to eight year periods into which the duration of exposure was split. In fact the mean calcaneal values in the three exposure duration groups were 60, 60, and 100 gg (g bone mineral)-' and the corresponding mean durations of exposure were 3 2, 11-8, and 21U2 years, so it is not readily possible from these data to estimate a half life. Further evidence for a difference between lead metabolism in cortical and in trabecular bone is provided by the gradation in ratios of the relevant parameters in former and active lead workers. That for integrated blood lead (presumably independent of any metabolically related half life) was 1 67 (SD 0-38), for tibial lead 1-54 (SD 0 46), and for calcaneal lead 0-96 (SD 0 21 with BPb expressed in umol 1' and the skeletal burden in mg. This gives a value for skeletal burden, corresponding to 1 jmol 1' of lead in blood, of 297 mg. These relations can be explored further by examining the regression relations of tibial and calcaneal lead and skeletal lead burden with integrated blood lead (BPb j.). 
